Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Neuroscience
|
October 19, 2004
Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning
J M Wehner, J J Keller, A B Keller, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 13, 2008
High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma
Julie L Ryan, Douglas R Morgan, Ricardo L Dominguez, et al.
Molecular Psychiatry
|
December 12, 2018
Common-variant associations with fragile X syndrome
James J Crowley, Jin Szatkiewicz, Anna K Kähler, et al.
Brain : a Journal of Neurology
|
May 19, 2016
CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids
Florian S Eichler, Jiankang Li, Yiran Guo, et al.
Molecular Pharmacology
|
January 18, 2014
Gα12 structural determinants of Hsp90 interaction are necessary for serum response element-mediated transcriptional activation
Ellyn R Montgomery, Brenda R S Temple, Kimberly A Peters, et al.
Molecular Psychiatry
|
September 25, 2019
Correction: Common-variant associations with fragile X syndrome
James J Crowley, Jin Szatkiewicz, Anna K Kähler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 6, 2003
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors
Changhai Cui, T K Booker, Roberta S Allen, et al.
Journal of Medicinal Chemistry
|
July 1, 2011
Structure-activity relationships of phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: investigations of various 6,5-heterocycles to improve metabolic stability
Markian M Stec, Kristin L Andrews, Shon K Booker, et al.
Journal of Medicinal Chemistry
|
May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives
Nobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 14, 2015
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
Jonathan S Berg, Ann Katherine M Foreman, Julianne M O'Daniel, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Neuroscience
|
October 19, 2004
Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning
J M Wehner, J J Keller, A B Keller, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 13, 2008
High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma
Julie L Ryan, Douglas R Morgan, Ricardo L Dominguez, et al.
Molecular Psychiatry
|
December 12, 2018
Common-variant associations with fragile X syndrome
James J Crowley, Jin Szatkiewicz, Anna K Kähler, et al.
Brain : a Journal of Neurology
|
May 19, 2016
CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids
Florian S Eichler, Jiankang Li, Yiran Guo, et al.
Molecular Pharmacology
|
January 18, 2014
Gα12 structural determinants of Hsp90 interaction are necessary for serum response element-mediated transcriptional activation
Ellyn R Montgomery, Brenda R S Temple, Kimberly A Peters, et al.
Molecular Psychiatry
|
September 25, 2019
Correction: Common-variant associations with fragile X syndrome
James J Crowley, Jin Szatkiewicz, Anna K Kähler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 6, 2003
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors
Changhai Cui, T K Booker, Roberta S Allen, et al.
Journal of Medicinal Chemistry
|
July 1, 2011
Structure-activity relationships of phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: investigations of various 6,5-heterocycles to improve metabolic stability
Markian M Stec, Kristin L Andrews, Shon K Booker, et al.
Journal of Medicinal Chemistry
|
May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives
Nobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 14, 2015
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
Jonathan S Berg, Ann Katherine M Foreman, Julianne M O'Daniel, et al.
Page
of 6